Skip to main content

Clearside Biomedical, Inc.

CLSDDelisted Dec 8, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001539029

Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Clearside Biomedical, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of CLSD: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders5446−8
Shares8.59M7.84M−755.1K (−8.8%)
Value$9.62M$6.82M−$2.81M (−29.2%)

New holders (5)

Institutions that held Clearside Biomedical, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to CLSD in Q3 2023
InstitutionSharesValue% of portfolio
XTX Topco Ltd27,545$24.0K0.00%
Wealth Enhancement Advisory Services, LLC20,000$17.4K0.00%
Stratos Wealth Advisors, LLC14,000$12.2K0.00%
Tower Research Capital LLC (TRC)10,836$9.43K0.00%
Qube Research & Technologies Ltd4$30.00%

Sold out (13)

Institutions that held Clearside Biomedical, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of CLSD in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
TownSquare Capital, LLC110,000$123.2K
Virtu Financial LLC33,844$38.0K
Millennium Management LLC33,298$37.3K
National Asset Management, Inc.31,000$34.7K
Two Sigma Investments, LP29,671$33.2K
Mackenzie Financial Corp28,669$32.4K
Newman Dignan & Sheerar, Inc.27,023$30.3K
Golden State Equity Partners19,780$22.2K
Jane Street Group, LLC15,946$17.9K
Two Sigma Securities, LLC15,719$17.6K
Connor, Clark & Lunn Investment Management Ltd.15,562$17.4K
UBS Group AG2,509$2.81K
FMR LLC1,940$2.17K